Plain-English translation of NCT07496957 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a newer device called the PRESERFLO MicroShunt works as well as a standard surgical procedure called trabeculectomy for treating open-angle glaucoma. Both are minimally invasive surgeries designed to lower the pressure inside your eye. The study will follow 100 patients over one year to compare how well each approach reduces eye pressure, reduces the need for eye drop medications, and prevents complications.
Open-angle glaucoma can lead to vision loss if eye pressure isn't controlled with medications. Some patients need surgery when eye drops alone don't work well enough. This trial exists to find out whether the newer PRESERFLO MicroShunt offers the same benefits as the traditional trabeculectomy procedure, which could give patients and doctors more treatment options.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to receive either the PRESERFLO MicroShunt or trabeculectomy surgery. You'll then attend follow-up visits over 12 months where the research team will measure your eye pressure, test your vision, take images of your eye, and check for any complications. You'll receive standard postoperative care and report any side effects or additional treatments you may need during the study year.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Poland